In the late 2000s, a pandemic of Pseudomonas syringae pv. actinidiae biovar 3 (Psa3) devastated kiwifruit orchards growing susceptible, yellow‐fleshed cultivars. New Zealand's kiwifruit industry has since recovered, following the deployment of the tolerant cultivar 'Zesy002'. However, little is known about the extent to which the Psa population is evolving since its arrival. Over 500 Psa3 isolates from New Zealand kiwifruit orchards were sequenced between 2010 and 2022, from commercial monocultures and diverse germplasm collections. While effector loss was previously observed on Psa‐resistant germplasm vines, effector loss appears to be rare in commercial orchards, where the dominant cultivars lack Psa resistance. However, a new Psa3 variant, which has lost the effector hopF1c , has arisen. The loss of hopF1c appears to have been mediated by the movement of integrative conjugative elements introducing copper resistance into this population. Following this variant's identification, in‐planta pathogenicity and competitive fitness assays were performed to better understand the risk and likelihood of its spread. While hopF1c loss variants had similar in‐planta growth to wild‐type Psa3, a lab‐generated ∆ hopF1c strain could outcompete the wild type on select hosts. Further surveillance was conducted in commercial orchards where these variants were originally isolated, with 6.6% of surveyed isolates identified as hopF1c loss variants. These findings suggest that the spread of these variants is currently limited, and they are unlikely to cause more severe symptoms than the current population. Ongoing genome biosurveillance of New Zealand's Psa3 population is recommended to enable early detection and management of variants of interest.
Pseudomonas syringae pv. actinidiae biovar 3 (Psa3) has decimated kiwifruit orchards growing susceptible kiwifruit Actinidia chinensis varieties. Effector loss has occurred recently in Psa3 isolates from resistant kiwifruit germplasm, resulting in strains capable of partially overcoming resistance present in kiwiberry vines (Actinidia arguta, Actinidia polygama, and Actinidia melanandra). Diploid male A. melanandra recognises several effectors, sharing recognition of at least one avirulence effector (HopAW1a) with previously studied tetraploid kiwiberry vines. Sequencing and assembly of the A. melanandra genome enabled the characterisation of the transcriptomic response of this non‐host to wild‐type and genetic mutants of Psa3. A. melanandra appears to mount a classic effector‐triggered immunity (ETI) response to wildtype Psa3 V‐13, as expected. Surprisingly, the type III secretion (T3SS) system‐lacking Psa3 V‐13 ∆hrcC strain did not appear to trigger pattern‐triggered immunity (PTI) despite lacking the ability to deliver immunity‐suppressing effectors. Contrasting the A. melanandra responses to an effectorless Psa3 V‐13 ∆33E strain and to Psa3 V‐13 ∆hrcC suggested that PTI triggered by Psa3 V‐13 was based on the recognition of the T3SS itself. The characterisation of both ETI and PTI branches of innate immunity responses within A. melanandra further enables breeding for durable resistance in future kiwifruit cultivars.
Host specificity of a plant pathogen is defined by its effector complement. However, it remains unclear whether the full complement is required for pathogenicity. Pseudomonas syringae pv. actinidiae (Psa) is an emerging model pathogen of kiwifruit with over 30 functional effectors, providing a unique opportunity to understand how host-mediated selection shapes pathogen evolution. The majority of Psa’s effectors previously appeared nonessential in single knockout contexts. Why, then, does Psa maintain such a large repertoire? We sought to examine effector requirements, redundancies, and repertoire refinement across host genotypes through a mutated effector-leveraging evolution experiment (MELEE), serially passaging competitive populations of effector knockout strains. Competition suggests that all effectors are collectively required for successful virulence, demonstrated by the dominance of wild-type. Host-specific effector requirements identified may further explain the maintenance of this large effector repertoire, providing important insights into the dynamics of effector redundancy following incursions.
In 2010, a Pseudomonas syringae pv. actinidiae biovar 3 (Psa3) incursion into New Zealand kiwifruit orchards devastated susceptible Actinidia chinensis cultivars. In contrast, many Actinidia species maintained in germplasm collections were resistant to Psa3 and showed limited symptoms. Recent genome biosurveillance revealed the emergence of widespread leaf spot symptoms in Psa3-resistant Actinidia germplasm. Surprisingly, few Psa3 isolates were recovered from symptomatic tissues, despite the frequent isolation of phenotypical Pseudomonas isolates on selective agar. Despite the poor recovery of Psa3 isolates, Psa3 was found in all symptomatic leaf tissue through qPCR and metabarcoding analysis. Metabarcoding revealed stark differences in bacterial community composition from samples taken from lesion-carrying or lesion-free material from the same leaf. Host genotype also appeared to influence community composition but to a lesser extent. Whole genome sequencing of diverse Pseudomonas spp. isolates revealed that many belonged to the P. syringae species complex. Curiously, the kiwifruit-associated P. syringae pv. actinidifoliorum (Pfm), was never recovered, nor were any other phylogroup 1 pathovars. Pathogenicity and competitive assays revealed that while individually diverse Pseudomonas isolates were not more pathogenic than Pfm or Psa3 on resistant Actinidia hosts, they could interact with Psa to sometimes improve their growth, suggesting that these isolates may form pathogenic consortia in these disease-associated phyllosphere communities on typically Psa3-resistant hosts. Graphical
Agathis australis (kauri), the only member of the ancient conifer family Araucariaceae in New Zealand, is colonised by arbuscular mycorrhizal (AM) fungi. The survival of A. australis is threatened by an Oomycota, Phytophthora agathidicida , the causal agent of kauri dieback. Phosphite injections into the trunk are the primary treatment for kauri dieback and have proven effective in reducing disease symptoms. However, the potential impact of phosphite treatment on AM fungal colonisation within A. australis roots and nodules has not been investigated. We conducted a preliminary investigation into whether AM fungi colonise phosphite‐treated trees. Using a combination of microscopy and metabarcoding of AM fungi 18S nuclear ribosomal small subunit genes, we demonstrate that AM fungi colonise the roots and nodules of A. australis trees three to 4 years post‐treatment. Glomeraceae was found to dominate, and AM fungi community composition and colonisation rates were comparable to previously reported values in trees not treated with phosphite. Soil pH, but not date of phosphite treatment or PA infection status, was found to significantly contribute to AM fungal community composition. This work highlights the importance in investigating colonisation events immediately after phosphite treatment of A. australis and a comparison with untreated trees. AM fungi are likely integral for A. australis forests to thrive, thus, ensuring they are protected in the treatment of kauri dieback is essential.